CE vs IRD · rev $10.28B vs rev $11.0M
Celanese Corporation (CE) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
CE currently screens at market cap $5.92B. IRD currently screens at market cap $35.7M.
Not investment advice. Open the CE and IRD stock pages for the full models.
Not investment advice.